LEMAITRE VASCULAR INC — Director's Dealing 2020

Dec 28, 2020

SEC Form 4/A — Form 4/A

Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2020-12-19

Reporting Person: Roberts David B (Director, President and Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-19	Common Stock	M	11	—	Acquired	53992	Direct
2020-12-19	Common Stock	F	160	$37.94	Disposed	53832	Direct
2020-12-20	Common Stock	M	5	—	Acquired	53837	Direct
2020-12-20	Common Stock	F	105	$37.94	Disposed	53732	Direct
2020-12-22	Common Stock	M	6	—	Acquired	53738	Direct
2020-12-22	Common Stock	F	119	$37.38	Disposed	53619	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-19	Dividend Equivalent Rights	$	M	11	Disposed		Common Stock (11)	Direct
2020-12-20	Dividend Equivalent Rights	$	M	5	Disposed		Common Stock (5)	Direct
2020-12-22	Dividend Equivalent Rights	$	M	6	Disposed		Common Stock (6)	Direct

Footnotes

F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F2: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 19, 2018. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

F3: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 20, 2019. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

F4: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 22, 2017. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.

F5: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 19, 2018. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F6: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 20, 2019. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F7: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 22, 2017. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.